Sjogren PP, Arnold RW, Skirko JR, Grimmer JF. Anatomic distribution of cervicofacial lymphatic malformations based on lymph node groups. Int J Pediatr Otorhinolaryngol. 2017;97:72–5.
Article
Google Scholar
Wiegand S, Eivazi B, Barth PJ, Von Rautenfeld DB, Folz BJ, Mandic R, et al. Pathogenesis of lymphangiomas. Virchows Arch. 2008;453:1–8.
Article
Google Scholar
Hogeling M, Adams S, Law J, Wargon O. Lymphatic malformations: clinical course and management in 64 cases. Australas J Dermatol. 2011;52:186–90.
Article
Google Scholar
Stone OA, Stainier DYR. Paraxial mesoderm is the major source of lymphatic endothelium. Dev Cell. 2019;50:247-255.e3.
Article
CAS
Google Scholar
Lerat J, Bisdorff-Bresson A, Borsic M, Chopinet C, Couloignier V, Fakhry N, et al. Guidelines (short version) of the French Society of Otorhinolaryngology (SFORL) on cervical lymphatic malformation in adults and children: diagnosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:109–12.
Article
CAS
Google Scholar
Luks VL, Kamitaki N, Vivero MP, Uller W, Rab R, Bovee JVMG, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015. https://doi.org/10.1016/j.jpeds.2014.12.069.
Article
Google Scholar
Zenner K, Cheng CV, Jensen DM, Timms AE, Shivaram G, Bly R, et al. Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations. JCI insight. 2019;4: e129884.
Article
Google Scholar
Martinez-Corral I, Zhang Y, Petkova M, Ortsäter H, Sjöberg S, Castillo SD, et al. Blockade of VEGF-C signaling inhibits lymphatic malformations driven by oncogenic PIK3CA mutation. Nat Commun. 2020;11:1–14.
Article
Google Scholar
Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics. 2015;136:e203–14.
Article
Google Scholar
Keppler-Noreuil KM, Rios JJ, Parker VER, Semple RK, Lindhurst MJ, Sapp JC, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet Part A. 2015;167:287–95.
Article
CAS
Google Scholar
Peranteau WH, Iyoob SD, Boelig MM, Khalek N, Moldenhauer JS, Johnson MP, et al. Prenatal growth characteristics of lymphatic malformations. J Pediatr Surg. 2017;52:65–8.
Article
Google Scholar
Olive A, Moldenhauer JS, Laje P, Johnson MP, Coleman BG, Victoria T, et al. Axillary lymphatic malformations: prenatal evaluation and postnatal outcomes. J Pediatr Surg. 2015;50:1711–5.
Article
Google Scholar
Dompmartin A, Ballieux F, Thibon P, Lequerrec A, Hermans C, Clapuyt P, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol. 2009;145:1239–44.
Article
CAS
Google Scholar
Perkins JA. New Frontiers in our understanding of lymphatic malformations of the head and neck: natural history and basic research. Otolaryngol Clin North Am. 2018;51:147–58.
Article
Google Scholar
Iacobas I, Adams DM, Pimpalwar S, Phung T, Blei F, Burrows P, et al. Multidisciplinary guidelines for initial evaluation of complicated lymphatic anomalies—expert opinion consensus. Pediatr Blood Cancer. 2020;67:e28036.
Article
Google Scholar
Phang MJ, Courtemanche DJ, Bucevska M, Malic C, Arneja JS. Spontaneously resolved macrocystic lymphatic malformations: predictive variables and outcomes. Plast Surg. 2017;25:27–31.
Article
Google Scholar
Perkins JA, Maniglia C, Magit A, Sidhu M, Manning SC, Chen EY. Clinical and radiographic findings in children with spontaneous lymphatic malformation regression. Otolaryngol Head Neck Surg. 2008;138:772–7.
Article
Google Scholar
Hyvönen H, Salminen P, Kyrklund K. Long-term outcomes of lymphatic malformations in children: an 11-year experience from a tertiary referral center. J Pediatr Surg. 2022;57:1005–10.
Article
Google Scholar
Horbach SER, Lokhorst MM, Saeed P, De Goüyon Matignon De Pontouraude CMF, Rothová A, Van Der Horst CMAM. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents. J Plast Reconstr Aesthetic Surg. 2016;69:295–304.
Article
Google Scholar
Tu JH, Do HM, Patel V, Yeom KW, Teng JMC. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population. J Neurointerv Surg. 2017;9:1022–5.
Article
Google Scholar
Wang Y, Tang W, Li X. Safety and efficacy of surgery combined with bleomycin irrigation for complex cervical–facial lymphatic malformations of children. Int J Pediatr Otorhinolaryngol. 2020;128: 109724.
Article
Google Scholar
Heit JJ, Do HM, Prestigiacomo CJ, Delgado-Almandoz JA, English J, Gandhi CD, et al. Guidelines and parameters: percutaneous sclerotherapy for the treatment of head and neck venous and lymphatic malformations. J Neurointerv Surg. 2017;9:611–7.
Article
Google Scholar
Lam SC, Yuen HKL. Medical and sclerosing agents in the treatment of orbital lymphatic malformations: what’s new? Curr Opin Ophthalmol. 2019;30:380–5.
Article
Google Scholar
Schreiber A, Soupre V, Kadlub N, Galliani E, Picard A, Chrétien-Marquet B, et al. Does surgery of lymphatic malformations lead to an increase in superficial lymphangiectasia? A retrospective study of 43 patients. Br J Dermatol. 2019;181:1324–5.
Article
CAS
Google Scholar
Balakrishnan K, Menezes MD, Chen BS, Magit AE, Perkins JA. Primary surgery vs primary sclerotherapy for head and neck lymphatic malformations. JAMA Otolaryngol Head Neck Surg. 2014;140:41–5.
Article
Google Scholar
Wang S, Du J, Liu Y, Zhang J, Ge W, Zhang Y, et al. Clinical analysis of surgical treatment for head and neck lymphatic malformations in children: a series of 128 cases. Acta Otolaryngol. 2019;139:713–9.
Article
Google Scholar
Lisan Q, Villepelet A, Parodi M, Garabedian ENEN, Blouin MJMJ, Couloigner V, et al. Value of radiofrequency ablation in the management of retropharyngeal lymphatic malformation. Int J Pediatr Otorhinolaryngol. 2016;83:37–40.
Article
Google Scholar
Leboulanger N, Roger G, Caze A, Enjolras O, Denoyelle F, Garabedian ENEN. Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma. Int J Pediatr Otorhinolaryngol. 2008;72:953–8.
Article
Google Scholar
Savas JA, Ledon J, Franca K, Chacon A, Zaiac M, Nouri K. Carbon dioxide laser for the treatment of microcystic lymphatic malformations (lymphangioma circumscriptum): a systematic review. Dermatologic Surg. 2013;39:1147–57.
Article
CAS
Google Scholar
Langbroek GB, Horbach SER, van der Vleuten CJM, Ubbink DT, van der Horst CMAM. Compression therapy for congenital low-flow vascular malformations of the extremities: a systematic review. Phlebology. 2018;33:5–13.
Article
Google Scholar
Parker VER, Keppler-Noreuil KM, Faivre L, Luu M, Oden NL, De Silva L, et al. Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum. Genet Med. 2019;21(5):1189–98.
Article
CAS
Google Scholar
Strychowsky JE, Rahbar R, O’Hare MJ, Irace AL, Padua H, Trenor CC. Sirolimus as treatment for 19 patients with refractory cervicofacial lymphatic malformation. Laryngoscope. 2018;128:269–76.
Article
CAS
Google Scholar
Adams DM, Trenor CC, Hammill AM, Vinks AA, Patel MN, Chaudry G, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137(2): e20153257.
Article
Google Scholar
Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A. Efficacy and safety of mammalian target of rapamycin inhibitors in vascular anomalies: a systematic review. Acta Derm Venereol. 2016;96:448–52.
Article
CAS
Google Scholar
Mizuno T, Fukuda T, Emoto C, Mobberley-Schuman PS, Hammill AM, Adams DM, et al. Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatr Blood Cancer. 2017. https://doi.org/10.1002/pbc.26470.
Article
Google Scholar
Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review. J Vasc Surg. 2020;71:318–27.
Article
Google Scholar
Shoji MK, Shishido S, Freitag SK. The use of sirolimus for treatment of orbital lymphatic malformations: a systematic review. Ophthal Plast Reconstr Surg. 2020;36:215–21.
Article
Google Scholar
Triana P, Miguel M, Díaz M, Cabrera M, López Gutiérrez JC. Oral sirolimus: An option in the management of neonates with life-threatening upper airway lymphatic malformations. Lymphat Res Biol. 2019;17:504–11.
Article
Google Scholar
Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, et al. Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical performus trial. JAMA Dermatol. 2021;157:1289–98.
Article
Google Scholar
Wang S, Zhang J, Ge W, Liu YY, Guo Y, Liu YY, et al. Efficacy and safety of oral sildenafil in treatment of pediatric head and neck lymphatic malformations. Acta Otolaryngol. 2017;137:674–8.
Article
CAS
Google Scholar
Leboulanger N, Garel C, Borde ITIT, Garabedian L, Denoyelle F. Propranolol therapy for hemorrhagic lymphangioma of the tongue. Arch Otolaryngol Head Neck Surg. 2011;137:813–5.
Article
Google Scholar
Maruani A, Brown S, Lorette G, Pondaven-Letourmy S, Herbreteau D, Eisenbaum A. Lack of effect of propranolol in the treatment of lymphangioma in two children. Pediatr Dermatol. 2013;30:383–5.
Article
Google Scholar
Venot Q, Blanc T, Rabia SH, Berteloot L, Ladraa S, Duong JP, et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature. 2018;558:540–6.
Article
CAS
Google Scholar
Laje P, Peranteau WH, Hedrick HL, Flake AW, Johnson MP, Moldenhauer JS, et al. Ex utero intrapartum treatment (EXIT) in the management of cervical lymphatic malformation. J Pediatr Surg. 2015;50:311–4.
Article
Google Scholar
Chen AW, Wang T, Huang YY, Liu SH. Multistage sclerotherapy for extensive lymphatic malformations with airway involvement in infant: a protocol to prevent tracheotomy. J Oral Maxillofac Surg. 2017;75:1882–90.
Article
Google Scholar
Meurisse V, Denamur S, Herbreteau D, Le Touze A, Favrais G, Pondaven-Letourmy S, et al. Efficacy of sirolimus combined with sclerotherapy for giant cervical lymphatic macrocystic malformations: two newborn cases. Eur J Dermatol. 2019;29:90–1.
Google Scholar
Livingston J, Alrowaily N, John P, Campisi P, Ranguis S, van Mieghem T, et al. Fetal therapy using rapamycin for a rapidly enlarging, obstructive, cervical lymphatic malformation: a case report. Prenat Diagn. 2021;41:884–7.
Article
Google Scholar
Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, et al. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet J Rare Dis. 2019. https://doi.org/10.1186/s13023-019-1118-1.
Article
Google Scholar
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57:1018–24.
Article
Google Scholar
Wiegand S, Wichmann G, DIetz A. Treatment of lymphatic malformations with the mTOR inhibitor sirolimus: a systematic review. Lymphat Res Biol. 2018;16:330–9.
Article
CAS
Google Scholar
Chaudry G, Guevara CJ, Rialon KL, Kerr C, Mulliken JB, Greene AK, et al. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol. 2014;37:1476–81.
Article
Google Scholar
Nassiri N, Rootman J, Rootman DB, Goldberg RA. Orbital lymphaticovenous malformations: current and future treatments. Surv Ophthalmol. 2015;60:383–405.
Article
Google Scholar
Rodriguez-Laguna L, Ibañez K, Gordo G, Garcia-Minaur S, Santos-Simarro F, Agra N, et al. CLAPO syndrome: identification of somatic activating PIK3CA mutations and delineation of the natural history and phenotype. Genet Med. 2018;20:882–9.
Article
CAS
Google Scholar
Vahidnezhad H, Youssefian L, Uitto J. Molecular genetics of the PI3K-AKT-mTOR pathway in genodermatoses: diagnostic implications and treatment opportunities. J Invest Dermatol. 2016;136:15–23.
Article
CAS
Google Scholar
Ozeki M, Fujino A, Matsuoka K, Nosaka S, Kuroda T, Fukao T. Clinical features and prognosis of generalized lymphatic anomaly, kaposiform lymphangiomatosis, and Gorham-Stout disease. Pediatr Blood Cancer. 2016;63:832–8.
Article
Google Scholar
Brouillard P, Boon L, Vikkula M. Genetics of lymphatic anomalies. J Clin Invest. 2014;124:898–904.
Article
CAS
Google Scholar
Blatt J, Finger M, Price V, Crary SE, Pandya A, Adams DM. Cancer risk in klippel-trenaunay syndrome. Lymphat Res Biol. 2019;17:630–6.
Article
Google Scholar
Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol. 2016;25:17–9.
Article
CAS
Google Scholar
Wagner KM, Lokmic Z, Penington AJ. Prolonged antibiotic treatment for infected low flow vascular malformations. J Pediatr Surg. 2018;53:798–801.
Article
Google Scholar